Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 37 to 48 of 135 entries
Sorted by: Best Match Show Resources per page
Barbiturate derivatives for managing multifaceted oncogenic pathways: A mini review.

Drug development research

Prasher P, Sharma M, Singh SP, Rawat DS.
PMID: 33210368
Drug Dev Res. 2021 May;82(3):364-373. doi: 10.1002/ddr.21761. Epub 2020 Nov 18.

Development and progression of metastasis comprises synchronized erroneous expressions of several composite pathways, which are difficult to manage simultaneously with the representative anticancer molecules. The emergence of the drug resistance and the complex interplay between these pathways further potentiates...

Cite
Prasher P, Sharma M, Singh SP, et al. Barbiturate derivatives for managing multifaceted oncogenic pathways: A mini review. Drug Dev Res. 2020;82(3):364-373doi: 10.1002/ddr.21761.
Prasher, P., Sharma, M., Singh, S. P., & Rawat, D. S. (2021). Barbiturate derivatives for managing multifaceted oncogenic pathways: A mini review. Drug development research, 82(3), 364-373. https://doi.org/10.1002/ddr.21761
Prasher, Parteek, et al. "Barbiturate derivatives for managing multifaceted oncogenic pathways: A mini review." Drug development research vol. 82,3 (2021): 364-373. doi: https://doi.org/10.1002/ddr.21761
Prasher P, Sharma M, Singh SP, Rawat DS. Barbiturate derivatives for managing multifaceted oncogenic pathways: A mini review. Drug Dev Res. 2021 May;82(3):364-373. doi: 10.1002/ddr.21761. Epub 2020 Nov 18. PMID: 33210368.
Copy Download .nbib Format: NLM
Assimilation of Expert Clinician Into the Academy: A Competency-Based Faculty Development Plan.

Nurse educator

Muirhead L, Brasher S, Vena C, Hall P, Cadet A.
PMID: 32568787
Nurse Educ. 2021 Mar-Apr 01;46(2):121-125. doi: 10.1097/NNE.0000000000000859.

BACKGROUND: As expert clinicians are recruited to academic positions in response to nursing faculty shortages, comprehensive plans are needed for transitioning and role development.PROBLEM: Schools of nursing often lack infrastructures to support and develop new faculty.APPROACH: Team members from...

Cite
Muirhead L, Brasher S, Vena C, et al. Assimilation of Expert Clinician Into the Academy: A Competency-Based Faculty Development Plan. Nurse Educ. 2021;46(2):121-125doi: 10.1097/NNE.0000000000000859.
Muirhead, L., Brasher, S., Vena, C., Hall, P., & Cadet, A. (2021). Assimilation of Expert Clinician Into the Academy: A Competency-Based Faculty Development Plan. Nurse educator, 46(2), 121-125. https://doi.org/10.1097/NNE.0000000000000859
Muirhead, Lisa, et al. "Assimilation of Expert Clinician Into the Academy: A Competency-Based Faculty Development Plan." Nurse educator vol. 46,2 (2021): 121-125. doi: https://doi.org/10.1097/NNE.0000000000000859
Muirhead L, Brasher S, Vena C, Hall P, Cadet A. Assimilation of Expert Clinician Into the Academy: A Competency-Based Faculty Development Plan. Nurse Educ. 2021 Mar-Apr 01;46(2):121-125. doi: 10.1097/NNE.0000000000000859. PMID: 32568787.
Copy Download .nbib Format: NLM
Oral Nanoemulsion of Fenofibrate: Formulation, Characterization, and .

Assay and drug development technologies

Gulati N, Kumar Chellappan D, Tambuwala, A A Aljabali A, Prasher P, Kumar Singh S, Anand K, Sharma A, Kumar Jha N, Gupta G, Dua K, Dureja H.
PMID: 33989048
Assay Drug Dev Technol. 2021 May-Jun;19(4):246-261. doi: 10.1089/adt.2021.012. Epub 2021 May 14.

Cite
Gulati N, Kumar Chellappan D, Tambuwala, et al. Oral Nanoemulsion of Fenofibrate: Formulation, Characterization, and . Assay Drug Dev Technol. 2021;19(4):246-261doi: 10.1089/adt.2021.012.
Gulati, N., Kumar Chellappan, D., Tambuwala, A A Aljabali, A., Prasher, P., Kumar Singh, S., Anand, K., Sharma, A., Kumar Jha, N., Gupta, G., Dua, K., & Dureja, H. (2021). Oral Nanoemulsion of Fenofibrate: Formulation, Characterization, and . Assay and drug development technologies, 19(4), 246-261. https://doi.org/10.1089/adt.2021.012
Gulati, Nisha, et al. "Oral Nanoemulsion of Fenofibrate: Formulation, Characterization, and ." Assay and drug development technologies vol. 19,4 (2021): 246-261. doi: https://doi.org/10.1089/adt.2021.012
Gulati N, Kumar Chellappan D, Tambuwala, A A Aljabali A, Prasher P, Kumar Singh S, Anand K, Sharma A, Kumar Jha N, Gupta G, Dua K, Dureja H. Oral Nanoemulsion of Fenofibrate: Formulation, Characterization, and . Assay Drug Dev Technol. 2021 May-Jun;19(4):246-261. doi: 10.1089/adt.2021.012. Epub 2021 May 14. PMID: 33989048.
Copy Download .nbib Format: NLM
Short midline catheters: High success rates for antibiotic therapy in children with cystic fibrosis.

The journal of vascular access

Glazner J, Steinfort K, Hu YJ, Browne W, Smith I, Brasher C.
PMID: 34296638
J Vasc Access. 2021 Jul 23;11297298211035310. doi: 10.1177/11297298211035310. Epub 2021 Jul 23.

OBJECTIVE: Short midline catheter use in paediatric populations appears to be increasing, however data on success rates and efficacy are sparse. This study aims to describe the success rate when midline venous catheters are employed as a single device...

Cite
Glazner J, Steinfort K, Hu YJ, et al. Short midline catheters: High success rates for antibiotic therapy in children with cystic fibrosis. J Vasc Access. 2021;11297298211035310doi: 10.1177/11297298211035310.
Glazner, J., Steinfort, K., Hu, Y. J., Browne, W., Smith, I., & Brasher, C. (2021). Short midline catheters: High success rates for antibiotic therapy in children with cystic fibrosis. The journal of vascular access, 11297298211035310. https://doi.org/10.1177/11297298211035310
Glazner, Judith, et al. "Short midline catheters: High success rates for antibiotic therapy in children with cystic fibrosis." The journal of vascular access vol. (2021): 11297298211035310. doi: https://doi.org/10.1177/11297298211035310
Glazner J, Steinfort K, Hu YJ, Browne W, Smith I, Brasher C. Short midline catheters: High success rates for antibiotic therapy in children with cystic fibrosis. J Vasc Access. 2021 Jul 23;11297298211035310. doi: 10.1177/11297298211035310. Epub 2021 Jul 23. PMID: 34296638.
Copy Download .nbib Format: NLM
Langerhans cell histiocytosis: Presentation in a preterm neonate.

Cancer reports (Hoboken, N.J.)

Fadhel Alvarez A, Patel SP, Brasher MI, Ruggiero JE, Aneji C.
PMID: 34156158
Cancer Rep (Hoboken). 2021 Jun 22;e1472. doi: 10.1002/cnr2.1472. Epub 2021 Jun 22.

BACKGROUND: Langerhans cell histiocytosis (LCH) is a rare disorder in which Langerhans cells (LC) accumulate in the skin or other organs and cause tumor formation or organ damage. Cutaneous lesions can vary widely and do not predict extent of...

Cite
Fadhel Alvarez A, Patel SP, Brasher MI, et al. Langerhans cell histiocytosis: Presentation in a preterm neonate. Cancer Rep (Hoboken). 2021;e1472doi: 10.1002/cnr2.1472.
Fadhel Alvarez, A., Patel, S. P., Brasher, M. I., Ruggiero, J. E., & Aneji, C. (2021). Langerhans cell histiocytosis: Presentation in a preterm neonate. Cancer reports (Hoboken, N.J.), e1472. https://doi.org/10.1002/cnr2.1472
Fadhel Alvarez, Ana, et al. "Langerhans cell histiocytosis: Presentation in a preterm neonate." Cancer reports (Hoboken, N.J.) vol. (2021): e1472. doi: https://doi.org/10.1002/cnr2.1472
Fadhel Alvarez A, Patel SP, Brasher MI, Ruggiero JE, Aneji C. Langerhans cell histiocytosis: Presentation in a preterm neonate. Cancer Rep (Hoboken). 2021 Jun 22;e1472. doi: 10.1002/cnr2.1472. Epub 2021 Jun 22. PMID: 34156158.
Copy Download .nbib Format: NLM
Persistent Hypoglycemia with Polycystic Kidneys: A Rare Combination - A Case Report.

Biomedicine hub

Prasher P, Redmond K, Stone H, Bailes J, Nehus E, Preston D, Werthammer J, Werthhammer.
PMID: 34055813
Biomed Hub. 2020 Dec 03;5(3):32-37. doi: 10.1159/000511389. eCollection 2020.

We present the case of an infant referred to our NICU born at 39 weeks' gestation with persistent hypoglycemia with elevated insulin levels (HI) requiring diazoxide to maintain normoglycemia. Additionally, polycystic kidney disease (PKD) was detected by ultrasound. Molecular...

Cite
Prasher P, Redmond K, Stone H, et al. Persistent Hypoglycemia with Polycystic Kidneys: A Rare Combination - A Case Report. Biomed Hub. 2020;5(3):32-37doi: 10.1159/000511389.
Prasher, P., Redmond, K., Stone, H., Bailes, J., Nehus, E., Preston, D., Werthammer, J., & Werthhammer. (2020). Persistent Hypoglycemia with Polycystic Kidneys: A Rare Combination - A Case Report. Biomedicine hub, 5(3), 32-37. https://doi.org/10.1159/000511389
Prasher, Priya, et al. "Persistent Hypoglycemia with Polycystic Kidneys: A Rare Combination - A Case Report." Biomedicine hub vol. 5,3 (2020): 32-37. doi: https://doi.org/10.1159/000511389
Prasher P, Redmond K, Stone H, Bailes J, Nehus E, Preston D, Werthammer J, Werthhammer. Persistent Hypoglycemia with Polycystic Kidneys: A Rare Combination - A Case Report. Biomed Hub. 2020 Dec 03;5(3):32-37. doi: 10.1159/000511389. eCollection 2020. PMID: 34055813; PMCID: PMC8136312.
Copy Download .nbib Format: NLM
Microfluidic chips: recent advances, critical strategies in design, applications and future perspectives.

Microfluidics and nanofluidics

Pattanayak P, Singh SK, Gulati M, Vishwas S, Kapoor B, Chellappan DK, Anand K, Gupta G, Jha NK, Gupta PK, Prasher P, Dua K, Dureja H, Kumar D, Kumar V.
PMID: 34720789
Microfluid Nanofluidics. 2021;25(12):99. doi: 10.1007/s10404-021-02502-2. Epub 2021 Oct 26.

Microfluidic chip technology is an emerging tool in the field of biomedical application. Microfluidic chip includes a set of groves or microchannels that are engraved on different materials (glass, silicon, or polymers such as polydimethylsiloxane or PDMS, polymethylmethacrylate or...

Cite
Pattanayak P, Singh SK, Gulati M, et al. Microfluidic chips: recent advances, critical strategies in design, applications and future perspectives. Microfluid Nanofluidics. 2021;25(12):99doi: 10.1007/s10404-021-02502-2.
Pattanayak, P., Singh, S. K., Gulati, M., Vishwas, S., Kapoor, B., Chellappan, D. K., Anand, K., Gupta, G., Jha, N. K., Gupta, P. K., Prasher, P., Dua, K., Dureja, H., Kumar, D., & Kumar, V. (2021). Microfluidic chips: recent advances, critical strategies in design, applications and future perspectives. Microfluidics and nanofluidics, 25(12), 99. https://doi.org/10.1007/s10404-021-02502-2
Pattanayak, Prapti, et al. "Microfluidic chips: recent advances, critical strategies in design, applications and future perspectives." Microfluidics and nanofluidics vol. 25,12 (2021): 99. doi: https://doi.org/10.1007/s10404-021-02502-2
Pattanayak P, Singh SK, Gulati M, Vishwas S, Kapoor B, Chellappan DK, Anand K, Gupta G, Jha NK, Gupta PK, Prasher P, Dua K, Dureja H, Kumar D, Kumar V. Microfluidic chips: recent advances, critical strategies in design, applications and future perspectives. Microfluid Nanofluidics. 2021;25(12):99. doi: 10.1007/s10404-021-02502-2. Epub 2021 Oct 26. PMID: 34720789; PMCID: PMC8547131.
Copy Download .nbib Format: NLM
Aerosolized Surfactant for Preterm Infants with Respiratory Distress Syndrome.

Children (Basel, Switzerland)

Brasher M, Raffay TM, Cunningham MD, Abu Jawdeh EG.
PMID: 34200535
Children (Basel). 2021 Jun 10;8(6). doi: 10.3390/children8060493.

Currently, the administration of surfactant to preterm infants with respiratory distress syndrome (RDS) mainly relies on intratracheal instillation; however, there is increasing evidence of aerosolized surfactant being an effective non-invasive strategy. We present a historical narrative spanning sixty years...

Cite
Brasher M, Raffay TM, Cunningham MD, et al. Aerosolized Surfactant for Preterm Infants with Respiratory Distress Syndrome. Children (Basel). 2021;8(6)doi: 10.3390/children8060493.
Brasher, M., Raffay, T. M., Cunningham, M. D., & Abu Jawdeh, E. G. (2021). Aerosolized Surfactant for Preterm Infants with Respiratory Distress Syndrome. Children (Basel, Switzerland), 8(6), . https://doi.org/10.3390/children8060493
Brasher, Mandy, et al. "Aerosolized Surfactant for Preterm Infants with Respiratory Distress Syndrome." Children (Basel, Switzerland) vol. 8,6 (2021). doi: https://doi.org/10.3390/children8060493
Brasher M, Raffay TM, Cunningham MD, Abu Jawdeh EG. Aerosolized Surfactant for Preterm Infants with Respiratory Distress Syndrome. Children (Basel). 2021 Jun 10;8(6). doi: 10.3390/children8060493. PMID: 34200535; PMCID: PMC8228799.
Copy Download .nbib Format: NLM
Effect of Real-Time Feedback Devices on Primary Care Patient Experience Scores: A Cluster-Randomized Trial.

Journal of patient experience

Philips K, Dadlez N, Fazzari M, Samuel S, Southern W, Heo M, Azad N, Drasher M, Rinke ML.
PMID: 34179376
J Patient Exp. 2021 Feb 26;8:2374373521996957. doi: 10.1177/2374373521996957. eCollection 2021.

Patient experience is a critical measure for ambulatory primary care, although it is unclear how to best improve patient experience scores. This study aimed to determine whether use of a real-time feedback (RTF) device improved patient experience scores in...

Cite
Philips K, Dadlez N, Fazzari M, et al. Effect of Real-Time Feedback Devices on Primary Care Patient Experience Scores: A Cluster-Randomized Trial. J Patient Exp. 2021;8:2374373521996957doi: 10.1177/2374373521996957.
Philips, K., Dadlez, N., Fazzari, M., Samuel, S., Southern, W., Heo, M., Azad, N., Drasher, M., & Rinke, M. L. (2021). Effect of Real-Time Feedback Devices on Primary Care Patient Experience Scores: A Cluster-Randomized Trial. Journal of patient experience, 82374373521996957. https://doi.org/10.1177/2374373521996957
Philips, Kaitlyn, et al. "Effect of Real-Time Feedback Devices on Primary Care Patient Experience Scores: A Cluster-Randomized Trial." Journal of patient experience vol. 8 (2021): 2374373521996957. doi: https://doi.org/10.1177/2374373521996957
Philips K, Dadlez N, Fazzari M, Samuel S, Southern W, Heo M, Azad N, Drasher M, Rinke ML. Effect of Real-Time Feedback Devices on Primary Care Patient Experience Scores: A Cluster-Randomized Trial. J Patient Exp. 2021 Feb 26;8:2374373521996957. doi: 10.1177/2374373521996957. eCollection 2021. PMID: 34179376; PMCID: PMC8205333.
Copy Download .nbib Format: NLM
Intraoperative cerebral oxygen saturation and neurological outcomes following surgical management of necrotizing enterocolitis.

Paediatric anaesthesia

Julien-Marsollier F, Cholet C, Coeffic A, Dupont T, Gauthier T, Loiselle M, Brouns K, Bonnard A, Biran V, Brasher C, Dahmani S.
PMID: 34984774
Paediatr Anaesth. 2022 Jan 05; doi: 10.1111/pan.14392. Epub 2022 Jan 05.

BACKGROUND: The goal of the present study was to investigate intraoperative factors associated with major neurological complications at 1 year following surgery for necrotizing enterocolitis.MATERIAL AND METHODS: the study consisted of a retrospective review of medical charts of patients...

Cite
Julien-Marsollier F, Cholet C, Coeffic A, et al. Intraoperative cerebral oxygen saturation and neurological outcomes following surgical management of necrotizing enterocolitis. Paediatr Anaesth. 2022;doi: 10.1111/pan.14392.
Julien-Marsollier, F., Cholet, C., Coeffic, A., Dupont, T., Gauthier, T., Loiselle, M., Brouns, K., Bonnard, A., Biran, V., Brasher, C., & Dahmani, S. (2022). Intraoperative cerebral oxygen saturation and neurological outcomes following surgical management of necrotizing enterocolitis. Paediatric anaesthesia, . https://doi.org/10.1111/pan.14392
Julien-Marsollier, Florence, et al. "Intraoperative cerebral oxygen saturation and neurological outcomes following surgical management of necrotizing enterocolitis." Paediatric anaesthesia vol. (2022). doi: https://doi.org/10.1111/pan.14392
Julien-Marsollier F, Cholet C, Coeffic A, Dupont T, Gauthier T, Loiselle M, Brouns K, Bonnard A, Biran V, Brasher C, Dahmani S. Intraoperative cerebral oxygen saturation and neurological outcomes following surgical management of necrotizing enterocolitis. Paediatr Anaesth. 2022 Jan 05; doi: 10.1111/pan.14392. Epub 2022 Jan 05. PMID: 34984774.
Copy Download .nbib Format: NLM
Folate, vitamin B(12), Down syndrome and Alzheimer's disease.

International journal of geriatric psychiatry

Prasher VP, Prasher M.
PMID: 27792280
Int J Geriatr Psychiatry. 2016 Dec;31(12):1372-1373. doi: 10.1002/gps.4519.

No abstract available.

Cite
Prasher VP, Prasher M. Folate, vitamin B(12), Down syndrome and Alzheimer's disease. Int J Geriatr Psychiatry. 2016;31(12):1372-1373doi: 10.1002/gps.4519.
Prasher, V. P., & Prasher, M. (2016). Folate, vitamin B(12), Down syndrome and Alzheimer's disease. International journal of geriatric psychiatry, 31(12), 1372-1373. https://doi.org/10.1002/gps.4519
Prasher, V P, and Prasher, M. "Folate, vitamin B(12), Down syndrome and Alzheimer's disease." International journal of geriatric psychiatry vol. 31,12 (2016): 1372-1373. doi: https://doi.org/10.1002/gps.4519
Prasher VP, Prasher M. Folate, vitamin B(12), Down syndrome and Alzheimer's disease. Int J Geriatr Psychiatry. 2016 Dec;31(12):1372-1373. doi: 10.1002/gps.4519. PMID: 27792280.
Copy Download .nbib Format: NLM
Anaesthesiologist workload during intra-operative paediatric anaesthesia.

European journal of anaesthesiology

Azale M, Julien-Marsollier F, Brasher C, Dahmani S.
PMID: 34857686
Eur J Anaesthesiol. 2022 Jan 01;39(1):79-80. doi: 10.1097/EJA.0000000000001522.

No abstract available.

Cite
Azale M, Julien-Marsollier F, Brasher C, et al. Anaesthesiologist workload during intra-operative paediatric anaesthesia. Eur J Anaesthesiol. 2022;39(1):79-80doi: 10.1097/EJA.0000000000001522.
Azale, M., Julien-Marsollier, F., Brasher, C., & Dahmani, S. (2022). Anaesthesiologist workload during intra-operative paediatric anaesthesia. European journal of anaesthesiology, 39(1), 79-80. https://doi.org/10.1097/EJA.0000000000001522
Azale, Mehdi, et al. "Anaesthesiologist workload during intra-operative paediatric anaesthesia." European journal of anaesthesiology vol. 39,1 (2022): 79-80. doi: https://doi.org/10.1097/EJA.0000000000001522
Azale M, Julien-Marsollier F, Brasher C, Dahmani S. Anaesthesiologist workload during intra-operative paediatric anaesthesia. Eur J Anaesthesiol. 2022 Jan 01;39(1):79-80. doi: 10.1097/EJA.0000000000001522. PMID: 34857686.
Copy Download .nbib Format: NLM
Showing 37 to 48 of 135 entries